++
+++
Essentials of Diagnosis
++
Unexplained abdominal crisis, generally in young women
Acute central or peripheral nervous system dysfunction
Recurrent psychiatric illnesses
Hyponatremia
Porphobilinogen in the urine during an attack
+++
General Considerations
++
Acute intermittent porphyria is caused by partial deficiency of hydroxymethylbilane synthase activity, leading to increased excretion of aminolevulinic acid and porphobilinogen in the urine
Genetics: mutation in the porphobilinogen deaminase gene
Autosomal dominant inheritance
It remains clinically silent in the majority of patients who carry a mutation in HMBS
Characteristic abdominal pain may be due to abnormalities in autonomic innervation in the gut
Cutaneous photosensitivity is absent
Attacks precipitated by numerous factors, including drugs and intercurrent infections
Hyponatremia resulting from inappropriate release of antidiuretic hormone and gastrointestinal loss of sodium
++
Usually presents in adulthood and has serious consequences
Clinical illness usually develops in women
Symptoms beginning in the teens or 20s, but in rare cases after menopause
++
Intermittent abdominal pain of varying severity, sometimes simulating an acute abdomen
Absence of fever and leukocytosis
Complete recovery between attacks
Autonomic neuropathy
Peripheral neuropathy, symmetric or asymmetric, mild or profound
CNS manifestations include
+++
Differential Diagnosis
++
Acute abdominal pain resulting from other cause, such as
Polyneuropathy resulting from other cause
Guillain-Barré syndrome
Lead or other heavy metal poisoning
Psychosis resulting from other cause
Syndrome of inappropriate antidiuretic hormone resulting from other cause
Dark urine resulting from other cause (eg, alkaptonuria)
++
Hyponatremia, often profound
Freshly voided urine is of normal color but may turn dark upon standing in light and air
Urine porphobilinogen increased during an acute attack
Most families have different mutations in HMBS
Mutation detection in the gene for porphobilinogen deaminase
++
Analgesics
Intravenous glucose
High-carbohydrate intake, a minimum of 300 g carbohydrate/day orally or intravenously
Hematin up to 4 mg/kg intravenously once or twice daily
Adverse consequences of hematin therapy include phlebitis and coagulopathy
+++
Therapeutic Procedures
++
High-carbohydrate diet diminishes the number of attacks
Withdrawal of the inciting agent
Liver transplantation for extreme cases
++
ECG
Electrolytes
Glucose
Mental status
++
Avoidance of factors known to precipitate attacks, especially drugs (Table 40–1)
Starvation diets must be avoided
Hormonal changes ...